Last updated on April 18, 2014 at 13:30 EDT

Latest Hillard M. Lazarus Stories

2012-03-15 17:18:00

University Hospitals Case Medical Center cancer researcher helps advance 'individualized' patient care with the find New research published in the March 15 issue of the New England Journal of Medicine (embargoed 5 pm ET March 14) identifies gene mutations associated with improved overall survival with higher doses of chemotherapy for patients with acute myeloid leukemia (AML). According to one of the authors, Hillard M. Lazarus, MD, Director of Novel Cell Therapy at Seidman Cancer...